Tag: Prescription Drugs
ADA: Canagliflozin Tied to Lower Risk of Cardiovascular Events
Lower risk versus placebo for patients with type 2 diabetes and high cardiovascular risk
ADA: Nasal Glucagon Feasible for Hypoglycemic Episodes
New product much easier to use than rescue injections, researcher says
Expedited Partner Therapy Helps Reduce STI Incidence
Lower chlamydia, gonorrhea rates seen when one person can obtain treatment for both partners
Lumacaftor, Ivacaftor Linked to Improved Lung Function in CF
Findings in patients aged 6 to 11 years with cystic fibrosis homozygous for F508del-CFTR
Several New Medications in the Pipeline to Prevent Migraine
New injectable drugs work by targeting calcitonin gene-related peptide
Young CA Survivors More Often Have Cost-Related Nonadherence
Risk of nonadherence was lower for survivors reporting a usual source of care than those without
Relapse Down With Clozapine, Injectables in Schizophrenia
Risk of rehospitalization substantially lower with long-acting injectables versus oral equivalents
Researchers Target Zolmitriptan Dosing for Pediatric Migraine
Study supports body-weight dosing of 5.0 mg and 2.5 mg for children >50 kg and <50 kg, respectively
SGLT2 Inhibitors Linked to Increased Risk of Ketoacidosis
Associated with approximately twice the risk of DKA compared to DPP4 inhibitors
Lithium’s Risk to Fetus May Be Lower Than Previously Thought
Increased risk of cardiac defects seen, but magnitude of effect smaller than previously postulated
